Development and validation of a serological potency test for the release of Leptospira vaccines - Requirements in the European Union

被引：0
|
作者：
Balks, Elisabeth [1 ]
Gyra, Heike [1 ]
Kobe, Babett [1 ]
Cussler, Klaus [1 ]
Werner, Esther [1 ]
机构：
[1] Paul Ehrlich Inst, Fed Inst Vaccines & Biomed, Vet Dept, Sect Bacterial Vaccines & Immune Sera, D-63225 Langen, Germany
来源：
BIOLOGICALS | 2013年 / 41卷 / 05期
关键词：
Leptospira; Vaccine; Batch potency; Alternative method; 3R; Serology; GUINEA-PIGS; CANDIDATES;
D O I：
10.1016/j.biologicals.2013.06.011
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Both European Pharmacopoeia Monograph 01/2008:0447 "Canine Leptospirosis vaccine (inactivated)" and the more recent Monograph 01/2008:1939 "Bovine Leptospirosis vaccine (inactivated)" explicitly allow for a sero-response test to assess batch potency. Test setup and requirements for in vivo and in vitro validation are described. Furthermore, the two main strategies to assess batch potency and their specific demands are addressed. (C) 2013 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：325 / 329
页数：5
相关论文
共 50 条
  • [1] Product-specific validation of a serological potency test for release of Leptospira vaccines in the European Union
    Stirling, Catrina
    Novokova, Viera
    BIOLOGICALS, 2013, 41 (05) : 330 - 331
  • [2] The maintenance of challenge strains used in the potency test for canine leptospira vaccines
    Reed, NE
    Varney, WC
    Goddard, RD
    Wyeth, PJ
    BIOLOGICALS, 2000, 28 (01) : 25 - 28
  • [3] Pertussis serological potency test as an alternative to the intracerebral mouse protection test: Development, evaluation and validation
    van der Ark, A
    van Straaten-van de Kappelle, I
    Hendriksen, CFM
    ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN, 1998, 15 : 33 - 36
  • [4] Licensing Requirements for Avian Vaccines Within the European Union
    Werner, Esther
    Sommer, Dagmar
    Rau, Henriette
    Kobe, Babett
    AVIAN DISEASES, 2023, 67 (04) : 474 - 479
  • [5] THE DEVELOPMENT OF A POTENCY TEST FOR LEPTOSPIRA-HARDJO VACCINES - A COMPARISON OF PROTECTION IN CALVES AND SEROLOGY IN GUINEA-PIGS
    GODDARD, RD
    HOPKINS, IG
    THORNTON, DH
    JOURNAL OF BIOLOGICAL STANDARDIZATION, 1986, 14 (04): : 337 - 344
  • [6] Successful Development and Validation of an in Vitro Replacement Assay for Leptospira Vaccine Potency Tests
    Kupa-Eddy, J.
    POTENCY TESTING OF VETERINARY VACCINES FOR ANIMALS: THE WAY FROM IN VIVO TO IN VITRO, 2012, 134 : 101 - 106
  • [7] Development of an in vitro potency test for inactivated Newcastle disease vaccines
    Maas, R
    de Winter, M
    Koch, G
    Oei, H
    Bongers, J
    PROGRESS IN THE REDUCTION, REFINEMENT AND REPLACEMENT OF ANIMAL EXPERIMENTATION, 2000, 31 : 959 - 967
  • [8] Technical requirements for the licensing of pseudorabies (Aujeszky's disease) vaccines in the European Union
    Vannier, P
    ADVANCES IN VETERINARY MEDICINE, VOL 41: VETERINARY VACCINES AND DIAGNOSTICS, 1999, 41 : 615 - 626
  • [9] APPROACHES TO VALIDATION OF ANIMAL TEST SYSTEMS FOR ASSAY FOR PROTECTIVE POTENCY OF BCG VACCINES
    SMITH, DW
    HARDING, GE
    JOURNAL OF BIOLOGICAL STANDARDIZATION, 1977, 5 (02): : 131 - 138
  • [10] Development and pre-validation of a quantitative multi-dose serological assay for potency testing of inactivated rabies vaccines for human use
    Moreira, Wildeberg Cal
    Freitas, Jessica F. S.
    Machado, Nathalia S.
    Castro Cardoso Almeida, Antonio Eugenio
    de Moura, Wlamir Correa
    JOURNAL OF VIROLOGICAL METHODS, 2019, 263 : 54 - 59
12345